72 A.C. Howlett
FimianiC,MattocksD,CavaniF,SalzetM,DeutschDG,PryorS,BilfingerTV,StefanoGB
(1999b) Morphine and anandamide stimulate intracellular calcium transients in human
arterial endothelial cells: coupling to nitric oxide release. Cell Signal 11:189–193
Freund TF, Katona I, Piomelli D (2003) Role of endogenous cannabinoids in synaptic
signaling. Physiol Rev 83:1017–1066
GalanteM,DianaMA(2004)GroupImetabotropicglutamatereceptorsinhibitGABArelease
at interneuron-Purkinje cell synapses through endocannabinoid production. J Neurosci
24:4865–4874
Galve-Roperh I, Rueda D, Gomez dP, Velasco G, Guzman M (2002) Mechanism of extracellu-
larsignal-regulatedkinaseactivationbytheCB(1)cannabinoidreceptor.MolPharmacol
62:1385–1392
Garcia DE, Brown S, Hille B, Mackie K (1998) Protein kinase C disrupts cannabinoid actions
by phosphorylation of the CB1 cannabinoid receptor. J Neurosci 18:2834–2841
Gebremedhin D, Lange AR, Campbell WB, Hillard CJ, Harder DR (1999) Cannabinoid CB1
receptor of cat cerebral arterial muscle functions to inhibit L-type Ca2+ channel current.
Am J Physiol 276:H2085–H2093
Gerard C, Mollereau C, Vassart G, Parmentier M (1990) Nucleotide sequence of a human
cannabinoid receptor cDNA. Nucleic Acids Res 18:7142
Gerdeman GL, Ronesi J, Lovinger DM (2002) Postsynaptic endocannabinoid release is
critical to long-term depression in the striatum. Nat Neurosci 5:446–451
Giuffrida A, Beltramo M, Piomelli D (2001) Mechanisms of endocannabinoid inactivation:
biochemistry and pharmacology. J Pharmacol Exp Ther 298:7–14
Glass M, Felder CC (1997) Concurrent stimulation of cannabinoid CB1 and dopamine D2
receptorsaugmentscAMPaccumulationinstriatalneurons:evidenceforaGslinkage
to the CB1 receptor. J Neurosci 17:5327–5333
Gomez del Pulgar T, Velasco G, Guzman M (2000) The CB1 cannabinoid receptor is coupled
to the activation of protein kinase B/Akt. Biochem J 347:369–373
Gonsiorek W, Lunn C, Fan X, Narula S, Lundell D, Hipkin RW (2000) Endocannabinoid
2-arachidonyl glycerol is a full agonist through human type 2 cannabinoid receptor:
antagonism by anandamide. Mol Pharmacol 57:1045–1050
Guhring H, Hamza M, Sergejeva M, Ates M, Kotalla CE, Ledent C, Brune K (2002) A role for
endocannabinoids in indomethacin-induced spinal antinociception. Eur J Pharmacol
454:153–163
GuoJ,IkedaSR(2004)EndocannabinoidsmodulateN-typecalciumchannelsandG-protein-
coupled inwardly rectifying potassium channels via CB1 cannabinoid receptors heterol-
ogously expressed in mammalian neurons. Mol Pharmacol 65:665–674
Guzman M, Sanchez C (1999) Effects of cannabinoids on energy metabolism. Life Sci
65:657–664
Hampson AJ, Bornheim LM, Scanziani M, Yost CS, Gray AT, Hansen BM, Leonoudakis DJ,
Bickler PE (1998) Dual effects of anandamide on NMDA receptor-mediated responses
and neurotransmission. J Neurochem 70:671–676
Hampson RE, Evans GJ, Mu J, Zhuang SY, King VC, Childers SR, Deadwyler SA (1995) Role of
cyclic AMP dependent protein kinase in cannabinoid receptor modulation of potassium
“A-current” in cultured rat hippocampal neurons. Life Sci 56:2081–2088
Hampson RE, Zhuang SY, Weiner JL, Deadwyler SA (2003) Functional significance of
cannabinoid-mediated, depolarization-induced suppression of inhibition (DSI) in the
hippocampus. J Neurophysiol 90:55–64
Harkany T, Hartig W, Berghuis P, Dobszay MB, Zilberter Y, Edwards RH, Mackie K, Ernfors
P (2003) Complementary distribution of type 1 cannabinoid receptors and vesicular
glutamate transporter 3 in basal forebrain suggests input-specific retrograde signalling
by cholinergic neurons. Eur J Neurosci 18:1979–1992
Henry DJ, Chavkin C (1995) Activation of inwardly rectifying potassium channels (GIRK1)
by co-expressed rat brain cannabinoid receptors in Xenopus oocytes. Neurosci Lett
186:91–94